Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,539,675 shares of VNDA stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,539,675
Previous 2,488,519
2.06%
Holding current value
$10.7 Million
Previous $11.9 Million
2.21%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding VNDA
# of Institutions
158Shares Held
44.6MCall Options Held
64.8KPut Options Held
562K-
Black Rock Inc. New York, NY8.14MShares$34.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.57MShares$15 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$14.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$9.91 Million0.7% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.14MShares$9.01 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $238M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...